ResMed has grown revenue 11% a year over three years and 12% a year over five, with earnings per share compounding at 21%. Revenue growth, 3-year annual rate: +11% (Medical Instruments & Supplies median +10%). Revenue growth, 5-year rate: +12%, growth has slowed since the five-year average. Earnings per share, 3-year rate: +21%, earnings outgrew revenue: margins or the share count worked for shareholders. Years of annual history on file: 17, FY2009 to FY2025, as filed.

RMDResMed

HealthcareUSD

$235.71

$182.8252 weeks$291.49

Is it growing?

Is RMD growing?

ResMed has grown revenue 11% a year over three years and 12% a year over five, with earnings per share compounding at 21%.

+11%

Revenue growth, 3-year annual rate · Medical Instruments & Supplies median +10% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +12%
Revenue growth, 5-year rate · +11% over three · growth has slowed since the five-year average
Earnings per share, 3-year rate: +21%
Earnings per share, 3-year rate · revenue +11% · earnings outgrew revenue: margins or the share count worked for shareholders
Years of annual history on file: 17
Years of annual history on file · FY2009 to FY2025, as filed